hema.to GmbH

hema.to is the world's first software service to provide end-to-end decision support: from raw flow files to a diagnostic report. hema.to provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data.

We empower hematology labs to increase efficiency while maintaining quality.